Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.43 |
| ▸ | TSHR | P16473 | 3/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.43 |
| ▸ | CASP1 | P29466 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | AKR1C2 | P52895 | 2/20 | 0.42 |
| ▸ | AKR1C1 | Q04828 | 2/20 | 0.42 |
| ▸ | AKR1C4 | P17516 | 1/20 | 0.42 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | HTT | P42858 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | PKM | P14618 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 3/20 | 0.40 |
| ▸ | DPP4 | P27487 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29764032 | 1.00 | CYP1A2 (0.44) | CYP1A2ALDH1A1TSHRTP53CASP1 | |
| SCHEMBL24455 | 0.93 | ALDH1A1 (0.45) | CYP1A2ALDH1A1TSHRTP53CASP1 | |
| SCHEMBL29764017 | 0.93 | ALDH1A1 (0.45) | CYP1A2ALDH1A1TSHRTP53CASP1 | |
| SCHEMBL31401887 | 0.91 | ALDH1A1 (0.41) | CYP1A2ALDH1A1TSHRTP53CASP1 | |
| SCHEMBL1204591 | 0.90 | CYP1A2 (0.56) | CYP1A2ALDH1A1TSHRTP53CASP1 | |
| SCHEMBL6735101 | 0.89 | ALDH1A1 (0.36) | CYP1A2ALDH1A1TSHRTP53CASP1 | |
| SCHEMBL6738393 | 0.82 | ALDH1A1 (0.37) | CYP1A2ALDH1A1TSHRTP53CASP1 | |
| SCHEMBL1456160 | 0.81 | ALDH1A1 (0.50) | CYP1A2ALDH1A1TSHRTP53CASP1 | |
| SCHEMBL2904787 | 0.81 | DPP4 (0.46) | CYP1A2ALDH1A1TSHRTP53CASP1 | |
| SCHEMBL7738805 | 0.79 | ALDH1A1 (0.45) | ALDH1A1TSHRTP53CASP1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1218 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240239982-A1 | THERMALLY TREATED POLYAMIC AMIDE AEROGEL | Blueshift Materials, Inc. | 2024-07-18 | — | — | US | claimed |
| CN-115232017-B | Compound, resin and preparation method and application thereof | 华为技术有限公司 | 2024-06-18 | — | — | CN | claimed |
| CN-118047948-A | Resin, preparation method thereof and resin composition | 华为技术有限公司 | 2024-05-17 | — | — | CN | claimed |
| US-11873379-B2 | Thermally treated polyamic amide aerogel | Blueshift Materials, Inc. (US) | 2024-01-16 | — | — | US | claimed |
| CN-117362741-A | Heat treated polyamide-amide aerogel | 蓝移材料有限公司 | 2024-01-09 | — | — | CN | claimed |
| CN-117304037-A | Diamine monomer, preparation method thereof, resin and application thereof | 华为技术有限公司 | 2023-12-29 | — | — | CN | claimed |
| CN-111433265-B | Heat treated polyamide-amide aerogel | 蓝移材料有限公司 | 2023-09-29 | — | — | CN | claimed |
| US-20230091989-A1 | DIAMINE MONOMER COMPOUND, METHOD FOR PREPARING THE SAME, RESIN, FLEXIBLE FILM, AND ELECTRONIC DEVICE | Zhen Ding Technology Co., Ltd. (TW) | 2023-03-23 | — | — | US | claimed |
| US-20230086746-A1 | DIAMINE MONOMER COMPOUND, METHOD FOR PREPARING THE SAME, RESIN, FLEXIBLE FILM, AND ELECTRONIC DEVICE | Zhen Ding Technology Co., Ltd. (TW) | 2023-03-23 | — | — | US | claimed |
| CN-108699277-B | Polymeric aerogels with improved mechanical and thermal properties | 蓝移材料有限公司 | 2022-12-02 | — | — | CN | claimed |
| WO-2002090422-A1 | POLYIMIDE COMPOSITION HAVING IMPROVED PEEL STRENGTH | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2002-11-14 | — | — | WO | claimed |
| US-20020010311-A1 | From polyamic acids | E.I. DU PONT DE NEMOURS AND COMPANY | 2002-01-24 | — | — | US | claimed |
| US-5690961-A | HYALURONIC ACID, ARTHRITIS, WOUND HEALING, COSMETICS | HERCULES INCORPORATED (US) | 1997-11-25 | — | — | US | claimed |
| EP-0718312-A2 | Crosslinked acidic polysaccharides and their uses | HERCULES INCORPORATED (US) | 1996-06-26 | — | — | EP | claimed |
| EP-0362649-B1 | Radiation-sensitive compositions and their use | BASF AG (DE) | 1994-03-02 | — | — | EP | claimed |
| US-5284734-A | Insulating layers and printed circuits; precursors for polyimides and polyquinazolines | BASF AKTIENGESELLSCHAFT (DE) | 1994-02-08 | — | — | US | claimed |
| US-5003078-A | Synthesis of phthalonitrile resins containing ether and imide linkages | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 1991-03-26 | — | — | US | claimed |
| US-4925915-A | FLUORINE CONTAINING POLYIMIDES | HOECHST CELANESE CORP. (US) | 1990-05-15 | — | — | US | claimed |
| EP-0362649-A2 | Radiation-sensitive compositions and their use | BASF Aktiengesellschaft (DE) | 1990-04-11 | — | — | EP | claimed |
| EP-0317944-A2 | Polymers prepared from 4,4'-bis-(2-(amino (halo) phenoxyphenyl) hexafluoroisopropyl) diphenyl ether | HOECHST CELANESE CORPORATION (US) | 1989-05-31 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230086746-A1 | DIAMINE MONOMER COMPOUND, METHOD FOR PREPARING THE SAME, RESIN, FLEXIBLE FILM, AND ELECTRONIC DEVICE | CDH1, RFT1, PADI1 | CYP1A2 4438/4885ALDH1A1 1307/4885TSHR 3857/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.